(1984). Intermediate dose methotrexate in childhood acute lymphocytic leukemia. European Paediatric Haematology and Oncology: Vol. 1, No. 1, pp. 113-118.
41 citations
Cite
SaveGo to paper →
Taylor & Francis
European Paediatric Haematology and Oncology Template
Write in a clean editor, then format for European Paediatric Haematology and Oncology in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the European Paediatric Haematology and Oncology format
European Paediatric Haematology and Oncology is a peer-reviewed journal published by Taylor & Francis, covering Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." European Paediatric Haematology and Oncology 12 (3): 45–58.
Formats any DOI in European Paediatric Haematology and Oncology style. No sign-up. |
| Publishes research in | Acute Lymphoblastic Leukemia research Acute Myeloid Leukemia Research Lymphoma Diagnosis and Treatment Childhood Cancer Survivors' Quality of Life Neuroblastoma Research and Treatments |
| Papers published last year | ≈42 |
| ISSN | 0800-2789 |
| h-index | 12 |
| i10-index | 12 |
| Total citations | 392 |
| Top institutions publishing here | Lund University |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Most-cited papers in European Paediatric Haematology and Oncology
In 25 patients previously treated extensively, ifosfamide with vincristine was used as last resource. Toxicity and antitumour effect were studied. All patients vomited. Haematuria and pancytopenia for more than one week were the main side effects. Thirteen patients responded. Six had a complete response. Four of these are now off therapy. Even although cyclophospha-mide was…
35 citations
Cite
SaveGo to paper →
Sixty children with Hodgkin's disease were clinically staged and treated by MOPP primary chemotherapy followed by 40 Gy nodal radiation limited to involved fields. Overall 5-year survival is 93% while relapse-free survival is 86%. Four patients relapsed. These results confirm that laparotomy no longer has a place in routine staging when chemotherapy is given to…
21 citations
Cite
SaveGo to paper →
Between October, 1977 and December, 1984, 61 children aged 5 months to 18 years (median 6.5) with solid tumours have been treated with high dose melphalan (HDM) 100–240 mg/m2 with autologous non-cryo-preserved bone marrow “rescue” to increase the rate of haematological recovery. Of these 61, 60 were evaluable on December 31st 1984; one patient was…
19 citations
Cite
SaveGo to paper →
Of 54 unselected patients with osteogenic sarcoma metastatic to the lung who were entered into two successive prospective studies in Western Germany and Austria, 16 presented with synchronous pulmonary metastases (PM) and primary rumor and 38 developed PM during or after chemotherapy. Eleven out of 29 patients (37.9%) undergoing one or more thoracotomies survived, for…
16 citations
Cite
SaveGo to paper →
Related journal templates
European Paediatric Haematology and Oncology template — frequently asked questions
How do I write a paper in the European Paediatric Haematology and Oncology format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the European Paediatric Haematology and Oncology template. When you export, DocuGuru compiles the paper into the official Taylor & Francis format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does European Paediatric Haematology and Oncology use?
European Paediatric Haematology and Oncology uses Author–year (Chicago, T&F) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." European Paediatric Haematology and Oncology 12 (3): 45–58.
Do I need to know LaTeX to submit to European Paediatric Haematology and Oncology?
No. DocuGuru generates the interact LaTeX class and compiles the PDF for you in the background, so you get a Taylor & Francis-ready European Paediatric Haematology and Oncology document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the European Paediatric Haematology and Oncology template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the European Paediatric Haematology and Oncology format with correct headings, figures, tables, and author–year citations.
Who publishes European Paediatric Haematology and Oncology?
European Paediatric Haematology and Oncology is a multidisciplinary journal published by Taylor & Francis. DocuGuru's European Paediatric Haematology and Oncology template matches Taylor & Francis's official submission format.
Can I export a submission-ready European Paediatric Haematology and Oncology PDF?
Yes — DocuGuru produces a PDF built with the official European Paediatric Haematology and Oncology template (the interact class) that is ready to submit to Taylor & Francis, together with the matching LaTeX source files.
How much does the European Paediatric Haematology and Oncology template cost?
You can start writing in the European Paediatric Haematology and Oncology template for free. Exporting the final submission-ready European Paediatric Haematology and Oncology PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.